Aera Therapeutics
PrivateLast Round
Series A
and B
Feb 16, 2023
Total Funding Raised
$193M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aera Therapeutics is a biotechnology company that develops proprietary delivery platforms, including protein nanoparticles, lipid nanoparticles, and antibody-oligonucleotide conjugates, to enable transformative genetic medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aera Therapeutics Comparables
Compare Aera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stylus Medicine | 89% | |
| Velvet Therapeutics | 85% | |
| Alaya.bio | 84% |
Aera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A and B | Feb 16, 2023 |
Key People
Founding team and executive leadership
Aera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series A and B |
| ARCH Venture Partners | Series A and B |
| Lux Capital | Series A and B |
| ARCH Venture Partners | Series A and B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 33% MoM, reaching 4.8K.
- Dec 2, 2025
Presented data on AERA-109, a targeted In Vivo CAR-T therapy.
Aera Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aera Therapeutics's valuation, stock price, and market status.
Is Aera a public or private company?
Aera is a private company.
What is the current stock price of Aera?
Aera is a private company with no public stock price. No recent secondary market data is available.
How much is Aera worth (valuation)?
Valuation information for Aera is not publicly available.
Can I buy Aera stock?
Aera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aera's last funding round?
Aera's most recent funding round was Series B on February 16, 2023.
Who are the main investors in Aera?
Key investors in Aera include GV, ARCH Venture Partners, Lux Capital, ARCH Venture Partners.
Will Aera IPO soon?
No public IPO plans have been announced for Aera.
How can I track Aera secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aera's secondary market activity and sign up for updates.